摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,3R,4S)-3-(3,4,5-trimethoxybenzyl)-4-(3,4,5-trimethoxyphenyl)-2-((R)-4-ethyl-2-oxo-oxazolidin-3-yl)-3,4-dihydro-2H-pyran-6-carboxylic acid methyl ester | 1296671-54-9

中文名称
——
中文别名
——
英文名称
(2R,3R,4S)-3-(3,4,5-trimethoxybenzyl)-4-(3,4,5-trimethoxyphenyl)-2-((R)-4-ethyl-2-oxo-oxazolidin-3-yl)-3,4-dihydro-2H-pyran-6-carboxylic acid methyl ester
英文别名
methyl (2R,3R,4S)-2-[(4R)-4-ethyl-2-oxo-1,3-oxazolidin-3-yl]-4-(3,4,5-trimethoxyphenyl)-3-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-2H-pyran-6-carboxylate
(2R,3R,4S)-3-(3,4,5-trimethoxybenzyl)-4-(3,4,5-trimethoxyphenyl)-2-((R)-4-ethyl-2-oxo-oxazolidin-3-yl)-3,4-dihydro-2H-pyran-6-carboxylic acid methyl ester化学式
CAS
1296671-54-9
化学式
C31H39NO11
mdl
——
分子量
601.651
InChiKey
UETGQXZFVIGFAO-QFIBFXAGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    43
  • 可旋转键数:
    13
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    120
  • 氢给体数:
    0
  • 氢受体数:
    11

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2R,3R,4S)-3-(3,4,5-trimethoxybenzyl)-4-(3,4,5-trimethoxyphenyl)-2-((R)-4-ethyl-2-oxo-oxazolidin-3-yl)-3,4-dihydro-2H-pyran-6-carboxylic acid methyl ester三氟甲磺酸三氟甲磺酸酐三氟化硼乙醚 、 manganese triacetate 作用下, 以 二氯甲烷 为溶剂, 反应 0.5h, 以32%的产率得到(8R,8aR,4bS,13aR)-8-((R)-4-ethyl-2-oxo-oxazolidin-3-yl)-4b,8,8a,9-tetrahydro-1,2,3,11,12,13-hexamethoxy-7-oxa-tribenzo[a,c,e]cycloheptene-6-carboxylic acid methyl ester
    参考文献:
    名称:
    New two-step sequence involving a hetero-Diels–Alder and a nonphenolic oxidative coupling reaction: a convergent access to analogs of steganacin
    摘要:
    A new family of analogs of steganacin, an important antimitotic compound, was accessed. It takes advantage of a completely stereoselective sequence of two key steps. The central dihydropyrane core is built by a highly diastereoselective and facially controlled hetero-Diels-Alder reaction. It is followed by a nonphenolic biaryl oxidative coupling with a complete atropo-stereoselectivity. It leads to a quick way to form cyclic biaryl lignans. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2011.01.097
  • 作为产物:
    参考文献:
    名称:
    New two-step sequence involving a hetero-Diels–Alder and a nonphenolic oxidative coupling reaction: a convergent access to analogs of steganacin
    摘要:
    A new family of analogs of steganacin, an important antimitotic compound, was accessed. It takes advantage of a completely stereoselective sequence of two key steps. The central dihydropyrane core is built by a highly diastereoselective and facially controlled hetero-Diels-Alder reaction. It is followed by a nonphenolic biaryl oxidative coupling with a complete atropo-stereoselectivity. It leads to a quick way to form cyclic biaryl lignans. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2011.01.097
点击查看最新优质反应信息

文献信息

  • New two-step sequence involving a hetero-Diels–Alder and a nonphenolic oxidative coupling reaction: a convergent access to analogs of steganacin
    作者:Mathieu Y. Laurent、Vivien Stocker、Valéry Momo Temgoua、Gilles Dujardin、Robert Dhal
    DOI:10.1016/j.tetlet.2011.01.097
    日期:2011.4
    A new family of analogs of steganacin, an important antimitotic compound, was accessed. It takes advantage of a completely stereoselective sequence of two key steps. The central dihydropyrane core is built by a highly diastereoselective and facially controlled hetero-Diels-Alder reaction. It is followed by a nonphenolic biaryl oxidative coupling with a complete atropo-stereoselectivity. It leads to a quick way to form cyclic biaryl lignans. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多